Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Mash Screen: high-throughput sequence containment estimation for genome discovery.

Ondov BD, Starrett GJ, Sappington A, Kostic A, Koren S, Buck CB, Phillippy AM.

Genome Biol. 2019 Nov 5;20(1):232. doi: 10.1186/s13059-019-1841-x.

2.

The case for BK polyomavirus as a cause of bladder cancer.

Starrett GJ, Buck CB.

Curr Opin Virol. 2019 Jul 20;39:8-15. doi: 10.1016/j.coviro.2019.06.009. [Epub ahead of print] Review.

PMID:
31336246
3.

Trichodysplasia spinulosa in a child: Identification of trichodysplasia spinulosa-associated polyomavirus in skin, serum, and urine.

Chamseddin BH, Tran BAPD, Lee EE, Pastrana DV, Buck CB, Wang RC, Kirkorian AY.

Pediatr Dermatol. 2019 Sep;36(5):723-724. doi: 10.1111/pde.13857. Epub 2019 Jun 12.

PMID:
31190328
4.

Merkel Cell Polyomavirus Infection and Detection.

Liu W, Krump NA, Buck CB, You J.

J Vis Exp. 2019 Feb 7;(144). doi: 10.3791/58950.

5.

Infectious Entry of Merkel Cell Polyomavirus.

Becker M, Dominguez M, Greune L, Soria-Martinez L, Pfleiderer MM, Schowalter R, Buck CB, Blaum BS, Schmidt MA, Schelhaas M.

J Virol. 2019 Mar 5;93(6). pii: e02004-18. doi: 10.1128/JVI.02004-18. Print 2019 Mar 15.

6.

Plerixafor for the Treatment of WHIM Syndrome.

McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH 3rd, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM.

N Engl J Med. 2019 Jan 10;380(2):163-170. doi: 10.1056/NEJMoa1808575.

7.

Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.

Pastrana DV, Peretti A, Welch NL, Borgogna C, Olivero C, Badolato R, Notarangelo LD, Gariglio M, FitzGerald PC, McIntosh CE, Reeves J, Starrett GJ, Bliskovsky V, Velez D, Brownell I, Yarchoan R, Wyvill KM, Uldrick TS, Maldarelli F, Lisco A, Sereti I, Gonzalez CM, Androphy EJ, McBride AA, Van Doorslaer K, Garcia F, Dvoretzky I, Liu JS, Han J, Murphy PM, McDermott DH, Buck CB.

mSphere. 2018 Dec 12;3(6). pii: e00645-18. doi: 10.1128/mSphereDirect.00645-18.

8.

Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.

Wunderink HF, de Brouwer CS, van der Meijden E, Pastrana DV, Kroes ACM, Buck CB, Feltkamp MCW.

J Clin Virol. 2019 Jan;110:22-28. doi: 10.1016/j.jcv.2018.11.009. Epub 2018 Dec 1.

9.

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.

Peretti A, Geoghegan EM, Pastrana DV, Smola S, Feld P, Sauter M, Lohse S, Ramesh M, Lim ES, Wang D, Borgogna C, FitzGerald PC, Bliskovsky V, Starrett GJ, Law EK, Harris RS, Killian JK, Zhu J, Pineda M, Meltzer PS, Boldorini R, Gariglio M, Buck CB.

Cell Host Microbe. 2018 May 9;23(5):628-635.e7. doi: 10.1016/j.chom.2018.04.005.

10.

Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Geoghegan EM, Pastrana DV, Schowalter RM, Ray U, Gao W, Ho M, Pauly GT, Sigano DM, Kaynor C, Cahir-McFarland E, Combaluzier B, Grimm J, Buck CB.

Cell Rep. 2017 Oct 31;21(5):1169-1179. doi: 10.1016/j.celrep.2017.10.027.

11.

Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States.

Gupta G, Kuppachi S, Kalil RS, Buck CB, Lynch CF, Engels EA.

Am J Transplant. 2018 Jan;18(1):245-252. doi: 10.1111/ajt.14530. Epub 2017 Nov 1.

12.

Identification of a Second Raccoon-Associated Polyomavirus.

Geoghegan EM, Welch NL, Yabsley MJ, Church ME, Pesavento PA, Buck CB.

Genome Announc. 2017 Jun 29;5(26). pii: e00548-17. doi: 10.1128/genomeA.00548-17.

13.

Complete Genome Sequence of a Polyomavirus Recovered from a Pomona Leaf-Nosed Bat (Hipposideros pomona) Metagenome Data Set.

Cantalupo PG, Buck CB, Pipas JM.

Genome Announc. 2017 Jan 19;5(3). pii: e01053-16. doi: 10.1128/genomeA.01053-16.

14.

Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses.

Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, Buck CB, Wang RC.

J Am Acad Dermatol. 2017 May;76(5):932-940.e3. doi: 10.1016/j.jaad.2016.11.035. Epub 2016 Dec 29.

15.

Genomic Sequence of Canine Papillomavirus 19.

Tisza MJ, Yuan H, Schlegel R, Buck CB.

Genome Announc. 2016 Dec 8;4(6). pii: e01380-16. doi: 10.1128/genomeA.01380-16.

16.

Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection.

Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, Xu X, Buck CB, You J.

Cell Host Microbe. 2016 Jun 8;19(6):775-87. doi: 10.1016/j.chom.2016.04.024. Epub 2016 May 19.

17.

The Ancient Evolutionary History of Polyomaviruses.

Buck CB, Van Doorslaer K, Peretti A, Geoghegan EM, Tisza MJ, An P, Katz JP, Pipas JM, McBride AA, Camus AC, McDermott AJ, Dill JA, Delwart E, Ng TF, Farkas K, Austin C, Kraberger S, Davison W, Pastrana DV, Varsani A.

PLoS Pathog. 2016 Apr 19;12(4):e1005574. doi: 10.1371/journal.ppat.1005574. eCollection 2016 Apr.

18.

Exposing the Molecular Machinery of BK Polyomavirus.

Buck CB.

Structure. 2016 Apr 5;24(4):495. doi: 10.1016/j.str.2016.03.011.

19.

Erratum for Pastrana et al., BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2015 Dec 17;90(1):624. doi: 10.1128/JVI.02585-15. Print 2016 Jan 1. No abstract available.

20.

The Oncogenic Small Tumor Antigen of Merkel Cell Polyomavirus Is an Iron-Sulfur Cluster Protein That Enhances Viral DNA Replication.

Tsang SH, Wang R, Nakamaru-Ogiso E, Knight SA, Buck CB, You J.

J Virol. 2015 Nov 25;90(3):1544-56. doi: 10.1128/JVI.02121-15. Print 2016 Feb 1.

21.

A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.

Cerqueira C, Pang YY, Day PM, Thompson CD, Buck CB, Lowy DR, Schiller JT.

J Virol. 2015 Nov 11;90(2):1096-107. doi: 10.1128/JVI.02497-15. Print 2016 Jan 15.

22.

Expression of the small T antigen of Lymphotropic Papovavirus is sufficient to transform primary mouse embryo fibroblasts.

Gupta T, Robles MT, Schowalter RM, Buck CB, Pipas JM.

Virology. 2016 Jan;487:112-20. doi: 10.1016/j.virol.2015.10.003. Epub 2015 Oct 27.

23.

JC polyomavirus mutants escape antibody-mediated neutralization.

Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV.

Sci Transl Med. 2015 Sep 23;7(306):306ra151. doi: 10.1126/scitranslmed.aab1720. Epub 2015 Sep 23.

24.

Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

Randhawa P, Pastrana DV, Zeng G, Huang Y, Shapiro R, Sood P, Puttarajappa C, Berger M, Hariharan S, Buck CB.

Am J Transplant. 2015 Apr;15(4):1014-20. doi: 10.1111/ajt.13083. Epub 2015 Mar 3.

25.

Genome Sequence of a Fish-Associated Polyomavirus, Black Sea Bass (Centropristis striata) Polyomavirus 1.

Peretti A, FitzGerald PC, Bliskovsky V, Pastrana DV, Buck CB.

Genome Announc. 2015 Jan 29;3(1). pii: e01476-14. doi: 10.1128/genomeA.01476-14.

26.

Hamburger polyomaviruses.

Peretti A, FitzGerald PC, Bliskovsky V, Buck CB, Pastrana DV.

J Gen Virol. 2015 Apr;96(Pt 4):833-9. doi: 10.1099/vir.0.000033. Epub 2015 Jan 7.

27.

WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome.

Siebrasse EA, Pastrana DV, Nguyen NL, Wang A, Roth MJ, Holland SM, Freeman AF, McDyer J, Buck CB, Wang D.

Emerg Infect Dis. 2015 Jan;21(1):103-6. doi: 10.3201/eid2101.140855.

28.

Detection of human polyomavirus 7 in human thymic epithelial tumors.

Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, Buck CB, De Baets MH, Zur Hausen A.

J Thorac Oncol. 2015 Feb;10(2):360-6. doi: 10.1097/JTO.0000000000000390.

29.

Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.

Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M Jr, Lifson JD, Xenophontos AM, Venzon D, Robert-Guroff M, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2014 Dec 15;193(12):6172-83. doi: 10.4049/jimmunol.1401504. Epub 2014 Nov 14.

30.

Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients.

Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proksell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Y.

J Infect Dis. 2015 May 15;211(10):1560-5. doi: 10.1093/infdis/jiu524. Epub 2014 Sep 17.

31.

Maturation of the human papillomavirus 16 capsid.

Cardone G, Moyer AL, Cheng N, Thompson CD, Dvoretzky I, Lowy DR, Schiller JT, Steven AC, Buck CB, Trus BL.

MBio. 2014 Aug 5;5(4):e01104-14. doi: 10.1128/mBio.01104-14.

32.

Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.

Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC.

JAMA Dermatol. 2014 Nov;150(11):1180-6. doi: 10.1001/jamadermatol.2014.1116.

PMID:
24943872
33.

Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication.

Tsang SH, Wang X, Li J, Buck CB, You J.

J Virol. 2014 Mar;88(6):3285-97. doi: 10.1128/JVI.03656-13. Epub 2014 Jan 3.

34.

A divergent variant of the eleventh human polyomavirus species, saint louis polyomavirus.

Pastrana DV, Fitzgerald PC, Phan GQ, Raiji MT, Murphy PM, McDermott DH, Velez D, Bliskovsky V, McBride AA, Buck CB.

Genome Announc. 2013 Oct 24;1(5). pii: e00812-13. doi: 10.1128/genomeA.00812-13.

35.

Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.

Handisurya A, Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT.

J Virol. 2013 Dec;87(24):13214-25. doi: 10.1128/JVI.02162-13. Epub 2013 Sep 25.

36.

The Merkel cell polyomavirus minor capsid protein.

Schowalter RM, Buck CB.

PLoS Pathog. 2013;9(8):e1003558. doi: 10.1371/journal.ppat.1003558. Epub 2013 Aug 22.

37.

BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2013 Sep;87(18):10105-13. doi: 10.1128/JVI.01189-13. Epub 2013 Jul 10. Erratum in: J Virol. 2016 Jan 1;90(1):624.

38.

The papillomavirus major capsid protein L1.

Buck CB, Day PM, Trus BL.

Virology. 2013 Oct;445(1-2):169-74. doi: 10.1016/j.virol.2013.05.038. Epub 2013 Jun 22. Review.

39.

Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation.

Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J.

J Virol. 2013 Aug;87(16):9173-88. doi: 10.1128/JVI.01216-13. Epub 2013 Jun 12.

40.

Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication.

Wang X, Li J, Schowalter RM, Jiao J, Buck CB, You J.

PLoS Pathog. 2012;8(11):e1003021. doi: 10.1371/journal.ppat.1003021. Epub 2012 Nov 8.

41.

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT.

J Clin Invest. 2012 Dec;122(12):4606-20. doi: 10.1172/JCI63287. Epub 2012 Nov 12.

42.

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Handisurya A, Day PM, Thompson CD, Buck CB, Kwak K, Roden RB, Lowy DR, Schiller JT.

Virology. 2012 Nov 25;433(2):385-94. doi: 10.1016/j.virol.2012.08.035. Epub 2012 Sep 15.

43.

Complete genome sequence of a tenth human polyomavirus.

Buck CB, Phan GQ, Raiji MT, Murphy PM, McDermott DH, McBride AA.

J Virol. 2012 Oct;86(19):10887. doi: 10.1128/JVI.01690-12.

44.

Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection.

Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T.

PLoS Pathog. 2012;8(7):e1002738. doi: 10.1371/journal.ppat.1002738. Epub 2012 Jul 26.

45.

Entry tropism of BK and Merkel cell polyomaviruses in cell culture.

Schowalter RM, Reinhold WC, Buck CB.

PLoS One. 2012;7(7):e42181. doi: 10.1371/journal.pone.0042181. Epub 2012 Jul 31.

46.

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.

Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB.

PLoS Pathog. 2012;8(4):e1002650. doi: 10.1371/journal.ppat.1002650. Epub 2012 Apr 12.

47.

Mucin biopolymers as broad-spectrum antiviral agents.

Lieleg O, Lieleg C, Bloom J, Buck CB, Ribbeck K.

Biomacromolecules. 2012 Jun 11;13(6):1724-32. doi: 10.1021/bm3001292. Epub 2012 May 21.

48.

The papillomavirus virion: a machine built to hide molecular Achilles' heels.

Buck CB, Trus BL.

Adv Exp Med Biol. 2012;726:403-22. doi: 10.1007/978-1-4614-0980-9_18. Review.

PMID:
22297524
49.

Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.

Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2012 Jan 15;188(2):714-23. doi: 10.4049/jimmunol.1101404. Epub 2011 Dec 14.

50.

No evidence for association of HPyV6 or HPyV7 with different skin cancers.

Schrama D, Buck CB, Houben R, Becker JC.

J Invest Dermatol. 2012 Jan;132(1):239-41. doi: 10.1038/jid.2011.261. Epub 2011 Sep 8. No abstract available.

Supplemental Content

Support Center